Jump to main content
Jump to site search


pH and reduction-activated polymeric prodrug nanoparticles based on 6-thioguanine-dialdehyde sodium alginate conjugate for enhanced intracellular drug release in leukemia

Abstract

For enhanced intracellular drug release in leukemia, thestructure of 6-thioguanine (6-TG) based pH/reduction responsive polymeric prodrug nanoparticles were constructed by conjugating 6-TG to dialdehyde sodium alginate (DSA) via acid-labile Schiff base linkage followed by the ultrasound-assisted oxidation of thiol groups to disulfide cross-links. The nanoparticles are stable at pH 7.4 containing 0 and 10 μM glutathione (GSH) with almost no drug release, but a cumulative release drug rate of up to 98.6 % in 228 h was observed at pH 5.0 with 20 mM GSH and the cumulative release drug in the first 48 hours was over three times as much as that in the case of 10 mM GSH, indicating that GSH and pH dual-stimulation can significantly elevate tumour cell-selective drug release. In comparison with free 6-TG, this system exhibited slightly higher inhibition ratio on HL-60 cancer cells while an obviously reduced cytotoxicity was observed for healthy liver cell line L-O2. Furthermore, in vitro cell studies further confirmed an efficient cellular uptake of the system and enhanced intracellular drug release in the HL-60 cells.

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Apr 2018, accepted on 10 May 2018 and first published on 11 May 2018


Article type: Paper
DOI: 10.1039/C8PY00577J
Citation: Polym. Chem., 2018, Accepted Manuscript
  •   Request permissions

    pH and reduction-activated polymeric prodrug nanoparticles based on 6-thioguanine-dialdehyde sodium alginate conjugate for enhanced intracellular drug release in leukemia

    Y. Wan, Y. Bu, J. Liu, J. Yang, W. Cai, Y. Yin, W. Xu, P. Xu, J. Zhang and M. He, Polym. Chem., 2018, Accepted Manuscript , DOI: 10.1039/C8PY00577J

Search articles by author

Spotlight

Advertisements